NSC 286193
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryA phase I trial of 2-β-D-ribofuranosylthiazole-4-carboxamide (NCS 286193, tiazofurin) was conducted using a 5-day i.v…
A pharmacokinetic study of tiazofurin was carried out in 13 patients treated in a phase I clinical trial of the drug and in 7…
A patient with refractory acute myeloid leukemia was treated with tiazofurin, an agent that causes inhibition of tumor cell…